Speak directly to the analyst to clarify any post sales queries you may have.
The digital breast tomosynthesis market is experiencing accelerated adoption as healthcare providers seek advanced imaging solutions that deliver improved patient outcomes and greater diagnostic confidence. Senior decision-makers evaluating next-generation technologies will find this report crucial for informed strategy and investment planning.
Market Snapshot: Digital Breast Tomosynthesis Market Overview
The Digital Breast Tomosynthesis Market grew from USD 4.41 billion in 2024 to USD 5.09 billion in 2025. It is expected to continue growing at a CAGR of 15.28%, reaching USD 13.77 billion by 2032. This strong market expansion underscores the increasing clinical reliance on layered imaging technologies for oncology diagnostics and the broader adoption across diverse healthcare settings worldwide.
Scope & Segmentation
- Component
- Hardware
- Services
- Software
- End User
- Academic and Research Institutes
- Breast Cancer Clinics
- Diagnostic Imaging Centers
- Hospitals
- Application
- Diagnostic
- Screening
- Technology
- Integrated Dbt
- Standalone Dbt
- Installation
- Fixed Unit
- Mobile Unit
- Geography
- Americas (North America, Latin America)
- Europe, Middle East & Africa
- Asia-Pacific
Companies included in competitive analysis are: Hologic, Inc.; GE HealthCare Technologies Inc.; Siemens Healthineers AG; Fujifilm Holdings Corporation; Koninklijke Philips N.V.; Konica Minolta, Inc.; Carestream Health, Inc.; Sectra AB; Shimadzu Corporation; Planmed Oy.
Key Takeaways for Decision-Makers
- Digital breast tomosynthesis advances are driving fundamental changes in clinical workflow integration, enabling more precise detection and patient-centric screening pathways.
- Global adoption is influenced by both developed and emerging market priorities, with variations in infrastructure, reimbursement policies, and clinical education initiatives affecting deployment speed and reach.
- Personalized screening protocols, powered by patient risk stratification and genetic data, are optimizing the frequency and coverage of imaging assessments for high-risk populations.
- Industry partnerships, especially between established imaging firms and technology disruptors, are fueling new innovations such as artificial intelligence-driven lesion analysis and decision support tools.
- Collaborative engagement between radiology, oncology, and IT stakeholders is fostering cohesive diagnostic ecosystems, integrating tomosynthesis outputs into broader electronic health record systems.
Tariff Impact and Market Accessibility
- Recent U.S. tariff modifications have affected procurement costs for imported imaging equipment and components, prompting both supplier localization and diversification of distribution strategies.
- Manufacturers and providers are responding with regional sourcing, alliances, and capital planning adjustments to maintain supply chain continuity and operational resilience.
Methodology & Data Sources
This report employs a mixed-methods research approach, consisting of in-depth interviews with key opinion leaders and analysis of primary data, supplemented by secondary reviews of scientific literature, clinical trials, and industry guidelines. Data validation uses triangulation methods, ensuring segment analysis—spanning components, technology formats, and regional adoption—is robust and actionable.
Why This Report Matters
- Enables leadership teams to benchmark technologies and identify growth opportunities within high-priority submarkets such as integrated platforms and mobile installations.
- Supports operational planning by outlining key dynamics, such as the impact of tariffs, supply chain shifts, and evolving reimbursement landscapes across global regions.
- Equips stakeholders with actionable insights that inform market entry, partnership selection, and investments in training and support services.
Conclusion
With a foundation built on technological progress and evolving care models, the digital breast tomosynthesis market is set to influence oncology imaging for years to come. Forward-thinking stakeholders can leverage these insights to optimize clinical integration, align with shifting regulatory landscapes, and enhance patient care experiences.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this Digital Breast Tomosynthesis market report include:- Hologic, Inc.
- GE HealthCare Technologies Inc.
- Siemens Healthineers AG
- Fujifilm Holdings Corporation
- Koninklijke Philips N.V.
- Konica Minolta, Inc.
- Carestream Health, Inc.
- Sectra AB
- Shimadzu Corporation
- Planmed Oy
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 186 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 5.09 Billion |
| Forecasted Market Value ( USD | $ 13.77 Billion |
| Compound Annual Growth Rate | 15.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
